<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>70(3)</volume><submitter>Campobasso D</submitter><journal>Central European journal of urology</journal><pagination>324-325</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5656377</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Very high-risk prostate cancer: multimodality treatment will be the new frontier.</pubmed_title><pmcid>PMC5656377</pmcid><pubmed_authors>Frattini A</pubmed_authors><pubmed_authors>Prati G</pubmed_authors><pubmed_authors>Campobasso D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Very high-risk prostate cancer: multimodality treatment will be the new frontier.</name><description/><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-18T19:46:39.42Z</modification><creation>2025-02-19T04:27:32.007Z</creation></dates><accession>S-EPMC5656377</accession><cross_references><pubmed>29104799</pubmed><doi>10.5173/ceju.2017.1535</doi></cross_references></HashMap>